Lyme Bacterium Predates U.S. Lab That Conspiracy Theorists Say Unleashed Ticks on the Public
On Jul. 18, 2019, the U.S. House of Representatives last week voted to order the Department of Defense…
-
-
Chembio Diagnostics and Takeda Pharmaceutical announced collaboration to develop point-of-care diagnostic test
On Jul. 18, 2019, Chembio Diagnostics announced a collaboration with Shire Human Genetic Therapies, a wholly owned subsidiary…
-
Vanderbilt Vaccine Center Director James Crow Jr, MD, was awarded half of the Future Insight Prize by Merck KGaA of Germany
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
-
Evotec completed acquisition of Just Biotherapeutics
On Jul. 3, 2019, Evotec announced that the strategic transaction to acquire Just Biotherapeutics, signed on 20 May…
-
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 signed into law
On Jun. 24, 2019, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (S.1379) passed by…
-
CanSinoBIO received approval for Its 13-valent penumococcal conjugate vaccine to start clinical trials
On Jun. 20, 2025, CanSino Biologics announced that it had received the National Medical Products Administration’s (NMPA) permission…
-
Columbia Sportswear’s Tim and Mary Boyle announced a $10 million gift to OHSU Knight Cancer Institute
On Jun. 18, 2019, Columbia Sportswear President and CEO Tim Boyle and his wife, Mary, announced a donation…
-
the largest stock of the rinderpest virus was destroyed at the Pirbright Institute
On Jun. 14, 2019, the Pirbright Institute announced that it had destroyed the last samples of rinderpest virus…
-
New CRISPR Lab for Genomic Research at UCSF and UC Berkeley in collaboratation with GlaxoSmithKline
On Jun. 13, 2019, the University of California, San Francisco and University of California, Berkeley collaborated with GlaxoSmithKline…
-
Groundbreaking DNA study launched to discover new connections between genetics & diseases
On Jun. 12, 2019, Intermountain Healthcare and deCODE genetics announced a major global collaboration and study focused on…
-
Genentech drug Polivy (polatuzumab vedotin-piiq) granted accelerated approval by FDA
On Jun. 10, 2019, Genentech announced the U.S. Food and Drug Administration (FDA) had granted accelerated approval to…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Vaccine
Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
-
Vaccitech universal flu vaccine passed Phase 2b clinical development milestones
On Jun. 5, 2019, Vaccitech announced that it had administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100)…
-
Penn received a $12 million grant to study the connection between cellular therapies and new methods of radiation therapy
On Jun. 3, 2019, the University of Pennsylvania (Penn) announced it had received a $12 million grant from…
-
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | U.S. Congress
The National Cancer Institute Annual Report to the Nation found cancer death rates continue to drop
On May 30, 2019, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
-
The Richard N. Merkin Institute for Translational Research was founded at CalTech
On May 30, 2019, The Richard N. Merkin Institute for Translational Research was founded at CalTech. Merkin, who…
-
FUJIFILM opened Life Science Strategic Business Office in Cambridge, Massachusetts
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
-
Amgen announced the launch of Amgen Community Oncology Research Collaborators
On May 28, 2019, Amgen, along with leading community oncology networks, announced the launch of Amgen Community Oncology…
-
At $2M, priciest ever medicine treats fatal genetic disease
On May 24, 2019, U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys…
-
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Neurology
FDA authorized marketing of first diagnostic test for detecting Zika virus antibodies
On May 23, 2019, the U.S. Food and Drug Administration (FDA) authorized marketing of a diagnostic test to…
-
The USDA announced a new vision for animal genomics
On May 16, 2019, a U.S. Department of Agriculture (USDA) blueprint, published in “Frontiers and Genetics,” will serve…
-
Chembio Diagnostics announced approval of Dengue point-of-care test by Brazilis Health Regulatory Agency
On May 7, 2019, Chembio Diagnostics announced the approval of its DPP Dengue System by Agência Nacional de…
-
U.S. FDA Approved Arctic® Fuji Apple
On May 2, 2019, the U.S. Food and Drug Authority (FDA) announced it had completed its voluntary review…
-
UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…
-
Massachusetts General Hospital received $200 million to advance research into complex diseases
On Apr. 25, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
-
GSK invested $100 million to expand long-term vaccine manufacturing capabilities in Hamilton
On Apr. 24, 2019, GSK announced $100 million of new investment in its manufacturing site in Hamilton, Montana…
-
St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease
On Apr. 18, 2019, St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease. By…
-
Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published
On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…
-
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
-
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
